During quarantine, Darnitsa supplied pharmacies with 3.6 million packages of paracetamol
4/28/2020 10:06 PM
Responding to the needs of Ukrainians in quarantine, the pharmaceutical company Darnitsa, in particular, increased the production of paracetamol and imustat.
This was stated in an interview with Ukrinform by the chairman of the board of directors of the Darnitsa group Dmitry Shimkiv, reports the agency.
“The demand for antipyretics and painkillers has increased the most. This is explained by the fact that approximately 80% of people infected with COVID-19 suffer from a mild illness while staying at home. These patients treat mainly the main symptoms of COVID-19 – fever and cough. ” – said Shimkiv.
See also: “Darnitsa” in five years has published more than 40 own developments
He pointed out that most of the national protocols of EU member states regarding treatment recommend the use of paracetamol to control fever and pain.
“We have increased its production – in March-April, 3.6 million packages were delivered to pharmacies. If necessary, we are ready to supply the market with this antipyretic,” said the chairman of the board.
Shimkiv also noted that there is a high demand for antiviral agents.
See also: COVID-19 treatment: Shimkiv spoke about the preparation of “Darnitsa” for the production of the drug
“Although there is still no single treatment protocol for COVID-19 worldwide, many countries are testing drugs against known coronaviruses, such as umifenovir, of which WHO is a potential candidate COVID-19. It is part of our antiviral drug Imustat, which is why it quickly disappeared from pharmacies. In response, we released 100,000 additional packages of the drug and received the raw materials. necessary for continued production, “he said.
According to the cost center, at 9 a.m. on April 28 in Ukraine, 9,410 laboratory-confirmed COVID-19 cases, of which 239 were fatal, 992 patients recovered. 401 new cases were recorded per day.
According to the materials: ukrinform.ru